Leveraging Canada For Quicker Oncology Site Start-Up
A biotech sponsor in the United States had targeted July 2015 for completion of enrollment for a Phase I dose-finding HER2+BrCa study.
How to Start-Up 9 Oncology Sites in 9 weeks
Over the last decade, increased competition for finite patient populations in the U.S. have led many drug developers to expand…
How to double your oncology enrolment targets
Back in June of 2011, a leading U.S. biotech company, currently developing multiple therapeutic candidates, was planning a Phase I/II…